Coastal Bridge Advisors’s Praxis Precision Medicines PRAX Stock Holding History

Coastal Bridge Advisors’s Portfolio PRAX Stock Details PRAX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.29M	Sell	3,846 -60	-2%	-$19K	0.08%	201
2026 Q1	$1.26M	Sell	3,906 -248	-6%	-$76.7K	0.09%	200
2025 Q4	$1.22M	Buy	4,154 +308	+8%	+$57.4K	0.09%	197
2025 Q3	$204K	Buy	+3,846	New	+$186K	0.02%	434
2025 Q1	–	Sell	-3,846	Closed	-$296K	–	424
2024 Q4	$296K	Hold	3,846	–	–	0.07%	116
2024 Q3	$221K	Buy	+3,846	New	+$208K	0.05%	149
2024 Q2	–	Sell	-3,846	Closed	-$235K	–	179
2024 Q1	$235K	Buy	+3,846	New	+$173K	0.05%	144

Other funds holding PRAX

Jupiter Topco New York $245B AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Coastal Bridge Advisors's PRAX Position: Q2 2026 in Review

Coastal Bridge Advisors reduced its Praxis Precision Medicines (PRAX) stake by 1.5% in Q2 2026, selling an estimated $19K and leaving 3,846 shares worth $1.29M. The position accounts for 0.08% of the portfolio, ranked #201.

Coastal Bridge Advisors first reported a position in PRAX in Q1 2024 and has held it in 7 quarters since. 309 funds tracked by Wall St. Rank hold PRAX as of Q2 2026.

Coastal Bridge Advisors held 3,846 shares of Praxis Precision Medicines worth $1.29M as of Q2 2026.
Coastal Bridge Advisors sold 60 Praxis Precision Medicines shares in Q2 2026, an estimated $19K.
Praxis Precision Medicines made up 0.08% of Coastal Bridge Advisors's portfolio in Q2 2026, its #201 holding.
Coastal Bridge Advisors first reported a position in Praxis Precision Medicines in Q1 2024 and has held it in 7 quarters since.
309 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q2 2026.

Based on Coastal Bridge Advisors's 13F filing for Q2 2026, filed 17 Aug 2026.